ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 08 May 2017
Last Applicant/ Owned by
One Johnson & Johnson Plaza
New Brunswick
NJ
08933
Serial Number
86223005 filed on 17th Mar 2014
Registration Number
N/A
Correspondent Address
Brian T. Jaenicke
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
ZURVANZ
Human pharmaceutical preparations for the prevention or treatment of auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases, excluding pharmaceutical preparations for the treatment of infectious-related diseases inc Read More
Classification Information
Class [005]
Pharmaceutical Products
Human pharmaceutical preparations for the prevention or treatment of auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases, excluding pharmaceutical preparations for the treatment of infectious-related diseases including anti-infective, anti-biotic, anti-viral, and anti-fungal preparations
Mark Details
Serial Number
No 86223005
Mark Type
No Service/Collective Mark
Attorney Docket Number
No T32740US2
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 08th May 2017 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 08th May 2017 | ABANDONMENT - NO USE STATEMENT FILED |
| 13th Oct 2016 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 12th Oct 2016 | EXTENSION 3 GRANTED |
| 28th Sep 2016 | EXTENSION 3 FILED |
| 28th Sep 2016 | TEAS EXTENSION RECEIVED |
| 28th Sep 2016 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 26th Apr 2016 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 23rd Apr 2016 | EXTENSION 2 GRANTED |
| 21st Mar 2016 | TEAS EXTENSION RECEIVED |